arrow
M

Makoto Kodaira

national cancer center - japan
H指数:26
被引数:2,663

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase Ia/Ib study of taselisib (GDC-0032), a potent and selective phosphoinositide 3-kinase inhibitor, in Japanese patients with advanced solid tumors or hormone receptor-positive locally advanced or metastatic breast cancer (JO29196 study)
2016-02-150
PRE
Molecular imaging using PET for breast cancer

使用PET进行乳腺癌的分子成像

2015-04-2816
PREAI
64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients

64Cu-DOTA-trastuzumab PET显像与HER2-positive乳腺癌患者脑转移HER2特异性研究

2015-03-1282
OAAI
A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors

人源化抗叶酸受体 α 单克隆抗体farletuzumab在实体瘤患者中的I期研究

2014-11-0926
OAAI